What you are talking about could apply to almost any company in this end of the market and this sector. You have laid out some numbers and voiced some fears. If your numbers are factual, then there is not really anything to discuss.
But then you already know that.
- Forums
- ASX - By Stock
- PNV
- Patent
Patent, page-14
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B |
Open | High | Low | Value | Volume |
$2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 299194 | $2.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.04 | 1559 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 299194 | 2.020 |
4 | 11182 | 2.010 |
9 | 86240 | 2.000 |
1 | 1500 | 1.995 |
2 | 2005 | 1.990 |
Price($) | Vol. | No. |
---|---|---|
2.040 | 1559 | 1 |
2.050 | 5436 | 2 |
2.060 | 4936 | 1 |
2.070 | 25500 | 2 |
2.100 | 10972 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online